GlassScriptPhysician profile
Vishal Raj
NPI 1427201128
$7,270.31
in general payments reported to CMS, 2019-2025
25 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $1,031 · 2021: $1,194 · 2022: $110 · 2023: $3,665 · 2024: $314 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $709 · Travel and Lodging: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $709.16 |
| Travel and Lodging | $420.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,436.38 | 2023 | Ion, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $658.49 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $588.43 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $542.25 | 2019-2021 | |
| Genzyme Corporation | $510.29 | 2019-2021 | |
| Viiv Healthcare Company | $380.99 | 2023-2024 | Dovato, Cabenuva |
| Sunovion Pharmaceuticals INC. | $227.36 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $155.75 | 2021 | |
| Advanced Respiratory, INC | $145.65 | 2020-2021 | |
| Abbvie INC. | $118.01 | 2022-2025 | |
| Pfizer INC. | $84.64 | 2020-2025 | |
| Circassia INC. | $72.28 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.28 | 2019 | |
| Mylan Specialty L.P. | $45.11 | 2020-2021 | |
| Inari Medical, INC. | $37.17 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $37.03 | 2020-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $27.10 | 2025 | Lumryz |
| Csl Behring | $24.46 | 2020 | |
| Pulmonx Corporation | $24.38 | 2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Genentech USA, INC. | $22.68 | 2019 | |
| Shire North American Group INC | $20.27 | 2019 | |
| Baxter Healthcare | $15.93 | 2022 | |
| United Therapeutics Corporation | $15.63 | 2025 | Tyvaso |
| Emd Serono, INC. | $14.41 | 2023 | Serostim |
| Teva Pharmaceuticals USA, INC. | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Raj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.